1. Home
  2. INAB vs OESX Comparison

INAB vs OESX Comparison

Compare INAB & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • OESX
  • Stock Information
  • Founded
  • INAB 2016
  • OESX 1996
  • Country
  • INAB United States
  • OESX United States
  • Employees
  • INAB N/A
  • OESX 260
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • OESX Building Products
  • Sector
  • INAB Health Care
  • OESX Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • OESX Nasdaq
  • Market Cap
  • INAB 24.0M
  • OESX 27.6M
  • IPO Year
  • INAB 2021
  • OESX 2007
  • Fundamental
  • Price
  • INAB $0.24
  • OESX $0.80
  • Analyst Decision
  • INAB Strong Buy
  • OESX Strong Buy
  • Analyst Count
  • INAB 3
  • OESX 1
  • Target Price
  • INAB $7.75
  • OESX $3.00
  • AVG Volume (30 Days)
  • INAB 750.7K
  • OESX 74.0K
  • Earning Date
  • INAB 11-12-2024
  • OESX 02-05-2025
  • Dividend Yield
  • INAB N/A
  • OESX N/A
  • EPS Growth
  • INAB N/A
  • OESX N/A
  • EPS
  • INAB N/A
  • OESX N/A
  • Revenue
  • INAB N/A
  • OESX $91,649,000.00
  • Revenue This Year
  • INAB N/A
  • OESX $11.01
  • Revenue Next Year
  • INAB N/A
  • OESX $17.06
  • P/E Ratio
  • INAB N/A
  • OESX N/A
  • Revenue Growth
  • INAB N/A
  • OESX 14.40
  • 52 Week Low
  • INAB $0.22
  • OESX $0.68
  • 52 Week High
  • INAB $1.93
  • OESX $1.53
  • Technical
  • Relative Strength Index (RSI)
  • INAB 38.43
  • OESX 48.08
  • Support Level
  • INAB $0.23
  • OESX $0.81
  • Resistance Level
  • INAB $0.32
  • OESX $0.99
  • Average True Range (ATR)
  • INAB 0.03
  • OESX 0.06
  • MACD
  • INAB -0.01
  • OESX 0.00
  • Stochastic Oscillator
  • INAB 10.62
  • OESX 51.61

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc is a developer, manufacturer, and seller of lighting and energy management systems. The company segments include Orion Lighting Segment, Orion Maintenance Segment and Orion Electric Vehicle Charging Segment. It derives maximum revenue from Lighting Segment.

Share on Social Networks: